All Stories

  1. Maternal Prebiotic Supplementation Modifies Associations Between Intrapartum Antibiotics and Infant Allergy
  2. Body mass index, prebiotic supplementation during pregnancy and gestational diabetes mellitus risk: an effect modification analysis from a randomised controlled trial
  3. Evaluation of a Clinical Risk Score for Preterm Necrotising Enterocolitis: The ‘Check‐ NEC Score’
  4. Optimising Vaginal Microbiome Profiling for Clinical Translation: A Comparative Assessment of Sample Storage Methods and a Vagina-Specific 16S rRNA Gene Database
  5. Optimising Vaginal Microbiome Profiling for Clinical Translation: A Comparative Assessment of Sample Storage Methods and a Vagina-Specific 16S rRNA Gene Database
  6. Colostrum as a Protective Factor Against Peanut Allergy: Evidence From a Birth Cohort
  7. Inhibition of interleukin-1 signaling protects against Group B streptococcus-induced preterm birth and fetal loss in mice
  8. Interleukin-1 Receptor Antagonists Partially Inhibited Histological Injury but Not Tissue Inflammation in a Sheep Model of Pregnancy
  9. Double-blind, randomised, placebo-controlled trial to evaluate the effectiveness of late gestation oral melatonin supplementation in reducing induction of labour rates in nulliparous women: the MyTIME study protocol
  10. Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial
  11. Reply to: Tolerance, Decision‐Making Processes and Medication Trials in Pregnancy
  12. The risk tolerance and decision‐making processes of Australian women regarding medication trials in pregnancy
  13. Effect of maternal prebiotic supplementation on human milk immunological composition: Insights from the SYMBA study
  14. Maternal prebiotic supplementation during pregnancy and lactation modifies the microbiome and short chain fatty acid profile of both mother and infant
  15. Pharmacological blockade of the interleukin-1 receptor suppressed Escherichia coli lipopolysaccharide-induced neuroinflammation in preterm fetal sheep
  16. Characterisation of Mid-Gestation Amniotic Fluid Cytokine and Bacterial DNA Profiles in Relation to Pregnancy Outcome in a Small Australian Cohort
  17. Asthma and allergies in a cohort of adolescents conceived with ART
  18. Associations between Prenatal Exposure to Phthalates and Features of the Metabolic Syndrome in Males from Childhood into Adulthood
  19. Longitudinal effects of prenatal exposure to plastic‐derived chemicals and their metabolites on asthma and lung function from childhood into adulthood
  20. Mental health and behavioural problems in adolescents conceived after ART
  21. Study Protocol for a Randomised Controlled Trial Investigating the Effects of Maternal Prebiotic Fibre Dietary Supplementation from Mid-Pregnancy to Six Months’ Post-Partum on Child Allergic Disease Outcomes
  22. Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort
  23. Offspring conceived through ART have normal thyroid function in adolescence and as young adults
  24. Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
  25. Asthma and allergies in offspring conceived by ART: a systematic review and meta-analysis
  26. Direct administration of the non-competitive interleukin-1 receptor antagonist rytvela transiently reduced intrauterine inflammation in an extremely preterm sheep model of chorioamnionitis
  27. The relationship between oxytocin blood concentrations and antidepressants over pregnancy and the postpartum
  28. Vaginal microbial profiling in a preterm birth high-risk cohort using shallow shotgun metagenomics
  29. A specific bacterial DNA signature in the vagina of Australian women in midpregnancy predicts high risk of spontaneous preterm birth (the Predict1000 study)
  30. Prenatal Testosterone Associates With Blood Pressure in Young Adults
  31. Associations between Prenatal Exposure to Phthalates and Timing of Menarche and Growth and Adiposity into Adulthood: A Twenty-Years Birth Cohort Study
  32. The influence of prenatal exposure to phthalates on subsequent male growth and body composition in adolescence
  33. A specific bacterial DNA signature in the vagina of Australian women in midpregnancy predicts high risk of spontaneous preterm birth (the Predict1000 study)
  34. Maternal perinatal depression, circulating oxytocin levels and childhood emotional disorders at 4 years of age: The importance of psychosocial context
  35. Use of stored serum in the study of time trends and geographical differences in exposure of pregnant women to phthalates
  36. Author Correction: Antenatal IL-1-dependent inflammation persists postnatally and causes retinal and sub-retinal vasculopathy in progeny
  37. Comparison of Bacterial DNA Profiles in Mid-Trimester Amniotic Fluid Samples From Preterm and Term Deliveries
  38. Targeting Toll‐like receptor‐4 to tackle preterm birth and fetal inflammatory injury
  39. Placental and intra-amniotic inflammation are associated with altered fetal immune responses at birth
  40. The Not-so-Sterile Womb: Evidence That the Human Fetus Is Exposed to Bacteria Prior to Birth
  41. Characterization of the bacterial microbiome in first‐pass meconium using propidium monoazide ( PMA ) to exclude nonviable bacterial DNA
  42. Re: “Amniotic fluid from healthy term pregnancies does not harbor a detectable microbial community” (2018) 6:87, https://doi.org/10.1186/s40168-018-0475-7
  43. Profiling bacterial communities in low biomass samples: pitfalls and considerations
  44. Murine exposure to gold nanoparticles during early pregnancy promotes abortion by inhibiting ectodermal differentiation
  45. Identification and removal of contaminating microbial DNA from PCR reagents: impact on low‐biomass microbiome analyses
  46. Intracellular speciation of gold nanorods alters the conformational dynamics of genomic DNA
  47. Relationship between umbilical cord sex hormone binding globulin, sex steroids, and age at menarche: a prospective cohort study
  48. The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio
  49. Antenatal IL-1-dependent inflammation persists postnatally and causes retinal and sub-retinal vasculopathy in progeny
  50. The Possible Impact of Antenatal Exposure to Ubiquitous Phthalates Upon Male Reproductive Function at 20 Years of Age
  51. Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?
  52. A Critical Review of the Bacterial Baptism Hypothesis and the Impact of Cesarean Delivery on the Infant Microbiome
  53. The impact of antenatal Bisphenol A exposure on male reproductive function at 20–22 years of age
  54. Comparison of Meconium DNA Extraction Methods for Use in Microbiome Studies
  55. Intrauterine inflammatory activation, functional progesterone withdrawal, and the timing of term and preterm birth
  56. Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus
  57. Recent advances in the prevention of preterm birth
  58. Maternal-placental-fetal biodistribution of multimodal polymeric nanoparticles in a pregnant rat model in mid and late gestation
  59. Progesterone to prevent preterm birth: the studies are getting better, but there is still room for improvement
  60. Reducing preterm birth by a statewide multifaceted program: an implementation study
  61. Cord blood androgen measurements: the importance of assay validation
  62. Applying Precision Public Health to Prevent Preterm Birth
  63. Umbilical cord androgens and estrogens in relation to verbal and nonverbal abilities at age 10 in the general population
  64. Umbilical cord blood androgen levels and ASD-related phenotypes at 12 and 36 months in an enriched risk cohort study
  65. The treatment of bacterial vaginosis in pregnancy with clindamycin to reduce the risk of infection-related preterm birth: a response to the Danish Society of Obstetrics and Gynecology guideline group's clinical recommendations
  66. Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota
  67. IFPA meeting 2015 workshop report III: nanomedicine applications and exosome biology, xenobiotics and endocrine disruptors and pregnancy, and lipid
  68. Preclinical evaluation of drugs to block inflammation-driven preterm birth
  69. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization
  70. Ureaplasma parvum genotype, combined vaginal colonisation with Candida albicans, and spontaneous preterm birth in an Australian cohort of pregnant women
  71. Early Life Events Predict Adult Testicular Function; Data Derived From the Western Australian (Raine) Birth Cohort
  72. Editorial: Advances in the Prevention and Treatment of Inflammation-Associated Preterm Birth
  73. A global survey of clinical trials in pregnancy
  74. A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy
  75. T cell cytokine responses to stimulation with Ureaplasma parvum in pregnancy
  76. Role of Wnt signalling in early pregnancy
  77. Changes in inflammatory mediators in gingival crevicular fluid following periodontal disease treatment in pregnancy: relationship to adverse pregnancy outcome
  78. Vaginal microbiota during pregnancy: Pathways of risk of preterm delivery in the absence of intrauterine infection?
  79. Testicular function in a birth cohort of young men
  80. Prenatal testosterone exposure is related to sexually dimorphic facial morphology in adulthood
  81. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin
  82. Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy
  83. The perinatal androgen to estrogen ratio and autistic-like traits in the general population: a longitudinal pregnancy cohort study
  84. In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts
  85. Whole blood flow cytometric analysis of Ureaplasma-stimulated monocytes from pregnant women
  86. Drugs to Block Cytokine Signaling for the Prevention and Treatment of Inflammation-Induced Preterm Birth
  87. In This Issue
  88. Paracrine communication modulates production of Wnt antagonists and COX1-mediated prostaglandins in a decidual-trophoblast co-culture model
  89. Decreased STAT3 in human idiopathic fetal growth restriction contributes to trophoblast dysfunction
  90. Intra-amniotic pharmacological blockade of inflammatory signalling pathways in an ovine chorioamnionitis model
  91. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors
  92. Adult digit ratio (2D:4D) is not related to umbilical cord androgen or estrogen concentrations, their ratios or net bioactivity
  93. Perinatal Testosterone Exposure and Cerebral Lateralisation in Adult Males: Evidence for the Callosal Hypothesis
  94. Effects of omega-3 and omega-6 fatty acids on human placental cytokine production
  95. The Maternal Serological Response to Intrauterine Ureaplasma sp. Infection and Prediction of Risk of Pre-Term Birth
  96. Trans-placental passage and anti-inflammatory effects of solithromycin in the human placenta
  97. Perinatal testosterone exposure and cerebral lateralisation in adult males: Evidence for the callosal hypothesis
  98. Letter to the editor: "Fatty acids and placental transport: insight or in vitro artifact?"
  99. Strategies to Prevent Preterm Birth
  100. Re-analysis of the association between perinatal androgens and pragmatic language ability
  101. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes
  102. Effects of nanoparticle size and gestational age on maternal biodistribution and toxicity of gold nanoparticles in pregnant mice
  103. Maternal Intravenous Administration of Azithromycin Results in Significant Fetal Uptake in a Sheep Model of Second Trimester Pregnancy
  104. Re-analysis of the association between perinatal androgens and postnatal head circumference growth
  105. Repeated maternal intramuscular or intraamniotic erythromycin incompletely resolves intrauterine Ureaplasma parvum infection in a sheep model of pregnancy
  106. Maternal Intravenous Treatment with either Azithromycin or Solithromycin Clears Ureaplasma parvum from the Amniotic Fluid in an Ovine Model of Intrauterine Infection
  107. Measurement of Androgen and Estrogen Concentrations in Cord Blood: Accuracy, Biological Interpretation, and Applications to Understanding Human Behavioral Development
  108. The Relationship between Umbilical Cord Estrogens and Perinatal Characteristics
  109. Effects of cytokine-suppressive anti-inflammatory drugs on inflammatory activation in ex vivo human and ovine fetal membranes
  110. Second trimester amniotic fluid cytokine concentrations, Ureaplasma sp. colonisation status and sexual activity as predictors of preterm birth in Chinese and Australian women
  111. High-Resolution Melt PCR Analysis for Genotyping of Ureaplasma parvum Isolates Directly from Clinical Samples
  112. Polymyxin B Agonist Capture Therapy for Intrauterine Inflammation
  113. Maternal Administration of Solithromycin, a New, Potent, Broad-Spectrum Fluoroketolide Antibiotic, Achieves Fetal and Intra-Amniotic Antimicrobial Protection in a Pregnant Sheep Model
  114. The influence of antenatal exposure to phthalates on subsequent female reproductive development in adolescence: a pilot study
  115. The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone
  116. Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta
  117. Placental ABC transporters, cellular toxicity and stress in pregnancy
  118. Umbilical Cord Blood Testosterone and Childhood Internalizing and Externalizing Behavior: A Prospective Study
  119. The association between perinatal testosterone concentration and early vocabulary development: A prospective cohort study
  120. The relationship between prenatal testosterone exposure and hemispheric asymmetry for language and spatial memory: A prospective cohort study
  121. Maternal Dietary Omega-3 Fatty Acid Supplementation Reduces Placental Oxidative Stress and Increases Fetal and Placental Growth in the Rat
  122. Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy
  123. Perinatal testosterone exposure and autistic-like traits in the general population: a longitudinal pregnancy-cohort study
  124. Ceramide biosynthesis and metabolism in trophoblast syncytialization
  125. Development of a Model for Functional Studies of ABCG2 (Breast Cancer Resistance Protein) Efflux Employing a Standard BeWo Clone (B24)
  126. Fetal Testosterone, Socio-Emotional Engagement and Language Development
  127. Androgen Concentrations in Umbilical Cord Blood and Their Association with Maternal, Fetal and Obstetric Factors
  128. Sphingosine–sphingosine-1-phosphate pathway regulates trophoblast differentiation and syncytialization
  129. Sex-specific associations between umbilical cord blood testosterone levels and language delay in early childhood
  130. Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF- B
  131. Inflammation of the Fetal Ovine Skin Following in utero Exposure to Ureaplasma parvum
  132. Homeobox gene Distal-less 3 (DLX3) is a regulator of villous cytotrophoblast differentiation
  133. ABCA1 and placental cholesterol efflux
  134. Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep
  135. Nanoparticulate Drug Delivery in Pregnancy: Placental Passage and Fetal Exposure
  136. Nanotoxicology: Nanoparticles versus the placenta
  137. Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth
  138. Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors
  139. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity
  140. Regulation of trophoblast migration and survival by a novel neural regeneration peptide
  141. Pharmacological inhibition of inflammatory pathways for prevention of preterm birth
  142. Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-κB kinase (IKK) inhibitors
  143. Innate inflammatory responses of human decidual cells to periodontopathic bacteria
  144. Antioxidant Defenses in the Rat Placenta in Late Gestation: Increased Labyrinthine Expression of Superoxide Dismutases, Glutathione Peroxidase 3, and Uncoupling Protein 2
  145. IFPA Meeting 2009 Workshops Report
  146. Prevention of Inflammatory Activation of Human Gestational Membranes in an Ex Vivo Model Using a Pharmacological NF- B Inhibitor
  147. Transport of lipids by ABC proteins: Interactions and implications for cellular toxicity, viability and function
  148. Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism
  149. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction
  150. Expression, Localisation and Activity of ATP Binding Cassette (ABC) Family of Drug Transporters in Human Amnion Membranes
  151. The Xenobiotic Transporter ABCG2 Plays a Novel Role in Differentiation of Trophoblast-like BeWo Cells
  152. Placental Enzymes and Transporters: New Functions and Genetic Polymorphisms – A Workshop Report
  153. Independent Regulation of Apical and Basolateral Drug Transporter Expression and Function in Placental Trophoblasts by Cytokines, Steroids, and Growth Factors
  154. Placental cytokines and preeclampsia
  155. Inflammation and normal labor
  156. Active transport across the human placenta: impact on drug efficacy and toxicity
  157. Gestational Age-Dependent Up-Regulation of Prostaglandin D Synthase (PGDS) and Production of PGDS-Derived Antiinflammatory Prostaglandins in Human Placenta
  158. Expression of TGF-β1, TGF-β2, TGF-β3 and the Receptors TGF-βRI and TGF-βRII in Placentomes of Artificially Inseminated and Nuclear Transfer Derived Bovine Pregnancies
  159. ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast
  160. Cytokines, Hypoxia, and Preeclampsia
  161. Suppressors of cytokine signaling proteins in human preterm placental tissues
  162. Nanomolar and Micromolar Effects of 15-Deoxy-Δ12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors γ and δ and Nuclear Factor κB
  163. Altered Placental Lactogen and Leptin Expression in Placentomes from Bovine Nuclear Transfer Pregnancies
  164. Paradoxical Proinflammatory Actions of Interleukin-10 in Human Amnion: Potential Roles in Term and Preterm Labour
  165. HUMAN PLACENTAL GLUCURONIDATION AND TRANSPORT OF 3′AZIDO-3′-DEOXYTHYMIDINE AND URIDINE DIPHOSPHATE GLUCURONIC ACID
  166. Insulin resistance is not due to persistently elevated serum tumor necrosis-alpha levels in small for gestational age, premature, or twin children
  167. Insulin-Like Growth Factor-I and Binding Proteins 1, 2, and 3 in Bovine Nuclear Transfer Pregnancies
  168. Drug Transfer and Metabolism by the Human Placenta
  169. 3′-Azido-3′-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta
  170. Epithelial Cell-Derived Neutrophil-Activating Peptide-78 Is Present in Fetal Membranes and Amniotic Fluid at Increased Concentrations with Intra-amniotic Infection and Preterm Delivery
  171. Macrophage inhibitory cytokine 1 in fetal membranes and amniotic fluid from pregnancies with and without preterm labour and premature rupture of membranes
  172. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL), TRAIL Receptors, and the Soluble Receptor Osteoprotegerin in Human Gestational Membranes and Amniotic Fluid during Pregnancy and Labor at Term and Preterm
  173. Cytokines, Prostaglandins and Parturition—A Review
  174. Maternal serum activin A is not elevated before preeclampsia in women who are at high risk
  175. Critical Paracrine Interactions Between TNF-  and IL-10 Regulate Lipopolysaccharide-Stimulated Human Choriodecidual Cytokine and Prostaglandin E2 Production
  176. Hypoxia Inhibits Activin A Production by Term Villous Trophoblast In Vitro
  177. Hypoxia Inhibits Activin A Production by Term Villous Trophoblast In Vitro
  178. Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption
  179. Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua
  180. Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua
  181. Efficacy and specificity of non-steroidal anti-inflammatory drugs for the inhibition of cytokine-stimulated prostaglandin E2 secretion by amnion-derived WISH cells
  182. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm
  183. Cytokines of the Placenta and Extra-placental Membranes: Roles and Regulation During Human Pregnancy and Parturition
  184. Cytokines of the Placenta and Extra-placental Membranes: Biosynthesis, Secretion and Roles in Establishment of Pregnancy in Women
  185. Identification of Suppressors of Cytokine Signaling (SOCS) Proteins in Human Gestational Tissues: Differential Regulation Is Associated with the Onset of Labor
  186. Identification of Suppressors of Cytokine Signaling (SOCS) Proteins in Human Gestational Tissues: Differential Regulation Is Associated with the Onset of Labor
  187. UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term
  188. Serum Activin A, Inhibin A, and Follistatin Concentrations in Preeclampsia or Small for Gestational Age Pregnancies
  189. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies
  190. Regulation of prostaglandin production in an immortalized human myometrial cell line by cytokines and non-steroidal anti-inflammatory drugs
  191. 15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells
  192. Expression of Interleukin-1β mRNA in Murine Uterine and Gestational Tissues: Relationship with Gestational Age1
  193. A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion
  194. Expression of prostaglandin H synthase-1 and -2 in murine intrauterine and gestational tissues from mid pregnancy until term
  195. Hypoxia Attenuates PGE2but Increases Prostacyclin and Thromboxane Production in Human Term Villous Trophoblast
  196. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1β, IL-6 and IL-8 with fetal fibronectin and cervical dilatation
  197. Cytosolic phospholipase A2and 15-hydroxyprostaglandin dehydrogenase mRNA expression in murine uterine and gestational tissues during late pregnancy
  198. Gestational age-dependent effects of lipopolysaccharide on prostaglandin production by murine decidual caps
  199. Regulation of activin a, inhibin a, and follistatin production in human amnion and choriodecidual explants by inflammatory mediators
  200. Corticotropin-releasing hormone, corticotropin-releasing hormone–binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor
  201. Intercellular Adhesion Molecule-1 (ICAM-1) in Cervicovaginal Fluid of Women Presenting with Preterm Labor: Predictive Value for Preterm Delivery
  202. The 15-Deoxy-Δ12,14-prostaglandin J2Receptor, Peroxisome Proliferator Activated Receptor-γ (PPARγ) is Expressed in Human Gestational Tissues and is Functionally Active in JEG3 Choriocarcinoma Cells
  203. Does Leptin Exhibit Cytokine-Like Properties in Tissues of Pregnancy?
  204. Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor
  205. Enhanced Expression of Intercellular Adhesion Molecule-1 (ICAM-1) in Amnion with Term and Preterm Labour
  206. Cytokine-induced coordinate expression of enzymes of prostaglandin biosynthesis and metabolism: 15-hydroxyprostaglandin dehydrogenase
  207. Activin A Exerts both Pro- and Anti-inflammatory Effects on Human Term Gestational Tissues
  208. Cytokine abundance in placental tissues: Evidence of inflammatory activation in gestational membranes with term and preterm parturition
  209. Characterization of the amnion-derived AV3 cell line for use as a model for investigation of prostaglandin-cytokine interactions in human amnion
  210. Concentrations of activin A, inhibin A and follistatin in human amnion, choriodecidual and placental tissues at term and preterm
  211. 15-Deoxy-Δ12,14-prostaglandin J2, a Ligand for Peroxisome Proliferator-Activated Receptor-γ, Induces Apoptosis in JEG3 Choriocarcinoma Cells
  212. Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review
  213. Regulation of Cytosolic Phospholipase A2 Expression by Cytokines in Human Amnion Cells
  214. Interleukin-4 differentially regulates prostaglandin production in amnion-derived WISH cells stimulated with pro-inflammatory cytokines and epidermal growth factor
  215. Expression of intercellular adhesion molecule-1 (ICAM-1) in choriodecidua with labour and delivery at term and preterm
  216. Labor-Associated Changes in Interleukin-10 Production and Its Regulation by Immunomodulators in Human Choriodecidua
  217. Effects of interleukin-4 on the expression and activity of prostaglandin endoperoxide H synthase-2 in amnion-derived WISH cells
  218. Comparative Studies on the Effects of Interleukin-4 and Interleukin-13 on Cytokine and Prostaglandin E2 Production by Amnion-derived WISH Cells
  219. Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines
  220. The Effects of a Ceramide Analogue, N-acetylsphingosine, on Basal and Tumor Necrosis Factor-α-Stimulated Production of Prostaglandins and Cytokines in Gestational Tissues
  221. Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide
  222. Regulation of Interleukin (IL)-6 and IL-8 Production in an Amnion-derived Cell Line by Cytokines, Growth Factors, Glucocorticoids, and Phorbol Esters
  223. Prostaglandin H synthase-2 and cytosolic phospholipase A2 in the hypoxic-ischemic brain: role in neuronal death or survival?
  224. The Molecular Mechanisms of Term and Preterm Labor: Recent Progress and Clinical Implications
  225. Serum Concentrations of Human Chorionic Gonadotrophs and Immunoreactive Inhibin in Early Pregnancy and Recurrent Miscarriage: A Longitudinal Study
  226. Activin-A stimulates, while transforming growth factor β1 inhibits,chorionic gonadotrophin production and aromatase activity in cultured human placental trophoblasts
  227. Comparative regulation of inhibin, activin and human chorionic gonadotropin production by placental trophoblast cells in culture
  228. Sex Differences in Umbilical Cord Serum Levels of Inhibin, Testosterone, Oestradiol Dehydroepiandrosterone Sulphate, and Sex Hormone-Binding Globulin in Human Term Neonates
  229. A radioimmunoassay for plasma dehydroepiandrosterone sulphate incorporating placental steroid sulphatase as a hydrolysing reagent